Circadian Rhythm Status and CS (Cesarean Section) Postoperative Pain
Launched by THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Jul 3, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how the body's natural internal clock, known as the circadian rhythm, affects pain after a cesarean section (C-section). Researchers will use a Huawei wristwatch to track the rhythm of mothers who are undergoing elective C-sections using a specific type of anesthesia. They want to see if there's a link between the timing of a mother's internal clock and her levels of pain after the surgery, which will be measured using a simple pain scale.
To participate in this study, women aged between 20 and 45 who are within 37-42 weeks of pregnancy and are scheduled for an elective C-section may be eligible. Participants will need to agree to join the study and provide informed consent. It's important to note that certain health conditions or medications may prevent some individuals from participating. Those who take part will help researchers understand more about how our body clocks can influence recovery after surgery, which could lead to better pain management in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 20 to 45
- • ASA(American society of anesthesiologists) status II-III
- • 37-42 weeks gestation
- • undergo elective cesarean section with subarachnoid anesthesia
- • participate in this study and sign informed consent
- Exclusion Criteria:
- • Patients with contraindications of combined spinal and epidural anesthesia
- • Patients with severe systemic disease
- • Alcoholism and long-term use of anti-inflammatory and analgesic drugs
- • Patients who were unable to cooperate or refused to participate in the trial
- • with psychiatric disorder
- • researchers considered unsuitable to participate in or unable to cooperate with the study
About The Second Affiliated Hospital Of Chongqing Medical University
The Second Affiliated Hospital of Chongqing Medical University is a leading healthcare institution dedicated to advancing medical research and patient care through innovative clinical trials. As a prominent academic hospital in China, it combines cutting-edge medical technology with a strong emphasis on education and training for healthcare professionals. The hospital is committed to conducting high-quality, ethically sound clinical research that contributes to the development of new therapies and enhances healthcare outcomes. With a multidisciplinary team of experts, the Second Affiliated Hospital fosters collaboration and strives to address critical health challenges through rigorous scientific investigation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chongqing, Chongqing, China
Patients applied
Trial Officials
Guangyou Duan, MD
Study Director
The Second Affiliated Hospital, Chongqing Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials